American Association for the Study of Liver Diseases The Liver Meeting 2023

Description

+ Include: 120 videos, size: 65.2 GB

+ Target Audience: gastroenterologists, surgeons, clinical pathologists and radiologists

+ Sample video: contact me for sample video

+ Information:

+ Topics:

Joint Courses & Plenaries

• AASLD–ASGE Endoscopy Course (Parts 1–4)

• AASLD–ILTS Transplant Course (Parts 1–4)

• AASLD–NASPGHAN Pediatric Symposia: Severe Acute Hepatitis; Hepatology Meets Hematology

• AASLD Japanese Joint Symposium: Cutting-Edge Diagnostics & Treatments in Chronic Liver Disease

• Clinical Plenary (1–2) • Basic Science Plenary • Transplant Surgery Plenary

• President’s Welcome • President’s Choice State-of-the-Art: Digitized Medicine

• Distinguished & State-of-the-Art Lectures: Hans Popper (Gene Therapy), Leon Schiff (Personalized HCC), Thomas E. Starzl (ALD & Transplant)

Guidelines, Practice & Workshops

• Practice Guidelines Workshop: What’s New

• Clinical Practice SIG • Public Health & Healthcare Delivery SIG: Applied Health Informatics

• Career Development Workshop • APP-Led Care & Quality Initiatives

• Surgery & Liver Transplantation Workshop (Parts 1–2)

• Postgraduate Course: Cirrhosis as a Multisystem Disorder (Parts 1–3)

Cirrhosis, Portal Hypertension & ACLF

• Ascites, AKI & Albumin

• Cirrhosis & Portal Hypertension: Brain–Gut Insights

• Portal Hypertension: Varices & Bleeding; Clinical/Experimental SIG + ACLF (Sessions 1–2)

• ACLF: Better Characterization & Treatment

• The Liver, the Heart & the Vascular System • Vascular Liver Disease: Bench to Bedside

Alcohol-Associated Liver Disease (ALD)

• ALD: Epidemiology, Mortality & Treatment

• Biomarkers to Building an ALD Research Program

• Early Liver Transplantation for Severe ALD: Selection, Prognostication & Monitoring

• ALD Experimental Pathogenesis

• ALD Debrief • Patient Programming (ALD)

Viral Hepatitis & Elimination

• HBV & HDV: Controversies; New Therapies; Virology/Immunology

• Hepatitis B SIG: Optimizing Diagnosis & Management for Elimination

• Hepatitis C: Innovations to Advance Elimination; Patient Programming; White House HCV Plan

• Hepatitis Elimination: A Global Vision

• Community Conversation: 2023 WHO HBV Global Guidelines

MASLD / MASH & Metabolic Liver Disease

• Epidemiology & Natural History of MASLD

• Approved & Available Therapeutics; Therapeutic Pipeline

• Non-Invasive Tests for MASLD/MASH

• Novel Biomarkers & Experimental Insights

• NAFLD Global Variations & Therapeutic Approaches

• Weight-Inclusive Care & Obesity Management (Multidisciplinary)

• Steatotic Liver Disease Nomenclature: Implementation

• MAFLD Patient Programming: Patient-Centered Management

• Mesenteric Adipose Tissue: Obesity, MASLD & IBD

Cholestatic & Autoimmune Liver Disease

• PBC, PSC & Cholangiocarcinoma: Global Management Updates

• Cholestatic/Autoimmune SIG: Gut–Liver Axis as a Therapeutic Target

• Breaking the Chains of Cholestatic Injury: Emerging Treatments

• Human & Experimental Cholestasis (Basic/Translational)

HCC & Liver Cancer

• Evolving Treatment Paradigms in HCC

• Liver Cancer SIG: Systemic Therapy from Early to Advanced HCC

• Novel Diagnostics in Liver Cancer

• Insights into Hepatocarcinogenesis (Basic Mechanisms)

• HCC Debrief • Patient Programming (Liver Cancer)

Transplantation

• Current Trends in Liver Transplants

• Transplant Tracker: Advances & Outcomes (Adults & Children)

• The Debrief: Liver Transplantation 2023

• Liver Transplantation & Surgery SIG

• Improving Access in Liver Transplantation

DILI & Hepatotoxicity

• Hepatotoxicity SIG

• Why Are You So Toxic? Mechanisms of Hepatotoxicity

• Hyman J. Zimmerman Lecture: Acetaminophen—Detection & Treatment (2023)

Microbiome, Gut–Liver Axis & Systems Science

• Gut Microbiota–Liver Crosstalk

• Bile Acids at the Cross-Road of Gut–Liver & Brain–Liver Axes (Parts 1–4)

• Decoding the Immunological Tango: Inflammation & Liver Disease

• Emerging Translational Approaches: Spatial Cellular Heterogeneity in CCA

• Targeting Genomics for Prognostics & Therapeutics

• Health Disparities & Social Determinants of Liver Health

Pediatrics & Rare Diseases

• Pediatric Hepatology: Basic Science & Clinical

• Pediatric Liver Disorders + NAFLD SIG (Parts 1–2)

• Pediatric & Rare Diseases: Patient Programming

Debriefs, Editorials & Honors

• Basic Science Debrief • The Editors’ Cut (Clinical; Basic/Translational)

• Distinguished Awards & Honors Ceremony

• The Gritty Ascent to Leadership for Women in GI/Hepatology

• Implementation Heroes: Masters of Care Delivery in Hepatology

• Evolving Impact of Hepatology Associates in Liver Care

• General Hepatology Update